Cardiff Oncology amends charter to increase authorized common stock
Cardiff Oncology amended its certificate of incorporation on Oct. 22, 2026, increasing the number of authorized common shares to 300 million. This authorization supports future share issuance for potential business development.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed